Our Products
OUR WIDE RANGE OF PRODUCTS
Pallets Exports
| Name | Category |
|---|---|
| Esomeprazole EC 40 mg and Domperidone SR 30 mg | Blended Pellets |
| Omeprazole EC 20 mg & Domperidone 10 mg | Blended Pellets |
| Pantoprazole EC 20 mg and Domperidone 10 mg | Blended Pellets |
| Pantoprazole EC 40 mg and Domperidone SR 30 mg | Blended Pellets |
| Pantoprazole EC 40 mg and Itopride HCl SR 150 mg | Blended Pellets |
| Rabeprazole Sod. EC 20 mg and Domperidone SR 30 mg | Blended Pellets |
| Rabeprazole Sod. EC 20 mg and Itopride HCl SR 150 mg | Blended Pellets |
| Pantoprazole 15% | Enteric Coated Micro Pellets |
| Lansoprazole Pellets 11.2% w/w | Enteric Coated Pellets |
| Omeprazole Pellets 7.5%, 8.5 %. 10%, 12% w/w | Enteric Coated Pellets |
| Pantoprazole Pellets 15%, 25% w/w | Enteric Coated Pellets |
| Rabeprazole Sodium Pellets 11.2%, 17%, 20% w/w | Enteric Coated Pellets |
| Domperidone Pellets 20%, 30%, 40% w/w | Sustained Release Pellets |
| Domperidone Pellets 8%, 13%, 15% w/w | Sustained Release Pellets |
| Immediate Release Pellets | Sustained Release Pellets |
| Itopride HCl Pellets 45%, 60% w/w | Sustained Release Pellets |
| Doxycycline Pellets 10 %, 15 % w/w | Under Development |
| Duloxetine Enteric coated Pellets 17.0% w/w | Under Development |
| Metoprolol HCL Pellets | Under Development |
| Tasmsulosin HCL Extended Release pellets 0.16% w/w | Under Development |
| Venlafexine HCL Extended Release pellets 10 %, 15 % w/w | Under Development |
Global Coverage
Galpha Laboratories is engaged in the manufacturing and marketing of Formulation (Finished Dosage Forms) in India.
